120 related articles for article (PubMed ID: 36739005)
1. Serum BDNF levels are involved in the diagnosis and treatment response in patients with PD.
Li R; Li J; Liu Y; Li D; Chu L; Zhang J; Luo X; Zhang Y
J Affect Disord; 2023 Apr; 327():31-37. PubMed ID: 36739005
[TBL] [Abstract][Full Text] [Related]
2. Serum BDNF levels and state anxiety are associated with somatic symptoms in patients with panic disorder.
Li J; Li R; Li D; Zhang J; Luo X; Zhang Y
Front Psychiatry; 2023; 14():1168771. PubMed ID: 37533888
[TBL] [Abstract][Full Text] [Related]
3. CREB1 and BDNF gene polymorphisms are associated with early treatment response to escitalopram in panic disorder.
Yang J; Li S; Lv H; Wang W; Zhang J; Chu L; Zhang Y
J Affect Disord; 2021 Jan; 278():536-541. PubMed ID: 33017682
[TBL] [Abstract][Full Text] [Related]
4. The roles of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) in predicting treatment remission in a Chinese Han population with generalized anxiety disorder.
Shen Z; Zhu J; Yuan Y; Ren L; Qian M; Lin M; Cai M; Zhang Z; Shen X
Psychiatry Res; 2019 Jan; 271():319-324. PubMed ID: 30529313
[TBL] [Abstract][Full Text] [Related]
5. Effects of Cytochrome P450 2C19 Genetic Polymorphisms on Responses to Escitalopram and Levels of Brain-Derived Neurotrophic Factor in Patients With Panic Disorder.
He Q; Mei Y; Liu Y; Yuan Z; Zhang J; Yan H; Shen L; Zhang Y
J Clin Psychopharmacol; 2019; 39(2):117-123. PubMed ID: 30742590
[TBL] [Abstract][Full Text] [Related]
6. The Relationship Among BDNF Val66Met Polymorphism, Plasma BDNF Level, and Trait Anxiety in Chinese Patients With Panic Disorder.
Chu L; Sun X; Jia X; Li D; Gao P; Zhang Y; Li J
Front Psychiatry; 2022; 13():932235. PubMed ID: 35815047
[TBL] [Abstract][Full Text] [Related]
7. Association between plasma levels of BDNF and GDNF and the diagnosis, treatment response in first-episode MDD.
Liu X; Li P; Ma X; Zhang J; Sun X; Luo X; Zhang Y
J Affect Disord; 2022 Oct; 315():190-197. PubMed ID: 35908604
[TBL] [Abstract][Full Text] [Related]
8. Differences in cytokines between patients with generalised anxiety disorder and panic disorder.
Zou Z; Zhou B; Huang Y; Wang J; Min W; Li T
J Psychosom Res; 2020 Jun; 133():109975. PubMed ID: 32220649
[TBL] [Abstract][Full Text] [Related]
9. Associations between brain-derived neurotrophic factor and cognitive impairment in panic disorder.
Wang W; Liu Y; Luo S; Guo X; Luo X; Zhang Y
Brain Behav; 2020 Dec; 10(12):e01885. PubMed ID: 33047489
[TBL] [Abstract][Full Text] [Related]
10. Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy.
Kobayashi K; Shimizu E; Hashimoto K; Mitsumori M; Koike K; Okamura N; Koizumi H; Ohgake S; Matsuzawa D; Zhang L; Nakazato M; Iyo M
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):658-63. PubMed ID: 15905010
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor in generalized anxiety disorder: results from a duloxetine clinical trial.
Ball S; Marangell LB; Lipsius S; Russell JM
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():217-21. PubMed ID: 23313564
[TBL] [Abstract][Full Text] [Related]
13. Gene×gene×gender interaction of BDNF and COMT genotypes associated with panic disorder.
Konishi Y; Tanii H; Otowa T; Sasaki T; Tochigi M; Umekage T; Motomura E; Shiroyama T; Kaiya H; Okazaki Y; Okada M
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():119-25. PubMed ID: 24508446
[TBL] [Abstract][Full Text] [Related]
14. Higher baseline serum adiponectin predicts better treatment remission in patients with generalized anxiety disorder treated with escitalopram.
Shen Z; Wang F; Cui L; Ren L; Hong X; Yuan Y; Shen X
Ann Palliat Med; 2021 Jul; 10(7):7634-7643. PubMed ID: 34353051
[TBL] [Abstract][Full Text] [Related]
15. The Association of BDNF Val66Met Polymorphism With Trait Anxiety in Panic Disorder.
Konishi Y; Tanii H; Otowa T; Sasaki T; Kaiya H; Okada M; Okazaki Y
J Neuropsychiatry Clin Neurosci; 2014; 26(4):344-51. PubMed ID: 26037856
[TBL] [Abstract][Full Text] [Related]
16. Ratio of plasma BDNF to leptin levels are associated with treatment response in major depressive disorder but not in panic disorder: A 12-week follow-up study.
An JH; Jang EH; Kim AY; Fava M; Mischoulon D; Papakostas GI; Na EJ; Jang J; Yu HY; Hong JP; Jeon HJ
J Affect Disord; 2019 Dec; 259():349-354. PubMed ID: 31465895
[TBL] [Abstract][Full Text] [Related]
17. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.
Matrisciano F; Bonaccorso S; Ricciardi A; Scaccianoce S; Panaccione I; Wang L; Ruberto A; Tatarelli R; Nicoletti F; Girardi P; Shelton RC
J Psychiatr Res; 2009 Jan; 43(3):247-54. PubMed ID: 18511076
[TBL] [Abstract][Full Text] [Related]
18. CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects.
Maron E; Tõru I; Mäemets K; Sepp S; Vasar V; Shlik J; Zharkovsky A
J Psychopharmacol; 2009 Jun; 23(4):460-4. PubMed ID: 18562429
[TBL] [Abstract][Full Text] [Related]
19. Pre-treatment peripheral biomarkers associated with treatment response in panic symptoms in patients with major depressive disorder and panic disorder: A 12-week follow-up study.
Kim K; Jang EH; Kim AY; Fava M; Mischoulon D; Papakostas GI; Kim H; Na EJ; Yu HY; Jeon HJ
Compr Psychiatry; 2019 Nov; 95():152140. PubMed ID: 31669792
[TBL] [Abstract][Full Text] [Related]
20. Brain derived neurotrophic factor (BDNF) levels in depressed women treated with open-label escitalopram.
Ladea M; Bran M
Psychiatr Danub; 2013 Jun; 25(2):128-32. PubMed ID: 23793276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
